Skip to content

Clinical trials

Phase 1 Urinary Bladder Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 1 Country / region: United Kingdom Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20091
20132
20141
20152
20171
20181
20192
20202
20212
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting6
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Pfizer2
Viralytics2
ADC Therapeutics S.A.1
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Cancer Research UK1
EMD Serono Research & Development Institute, Inc.1
Genentech, Inc.1
Imperial College London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms21
Carcinoma, Non-Small-Cell Lung12
Ovarian Neoplasms10
Squamous Cell Carcinoma of Head and Neck7
Esophageal Neoplasms6
Melanoma6
Breast Neoplasms5
Colorectal Neoplasms5
Head and Neck Neoplasms5
Stomach Neoplasms5

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.